Immunoreactant carrier
US12343406B2 · kind B2 · utility
0Cited by
2References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 3, 2019 |
| Grant date | Jul 1, 2025 |
| Priority date | — |
| Expiry date | Jan 20, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An immunoreactive substance carrier according to an embodiment of the present invention may stably deliver various immunoreactive substances including antibodies and/or cytokines, to a target site, thereby exhibiting excellent immunotherapeutic effects. Therefore, a composition including the immunoreactive substance carrier can be used for immunotherapy, thereby having excellent effects in the prevention or treatment of cancer or various immune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.